急性缺血心肌炎症与再灌注  

Inflammation of Acute Ischemic Cardiac Muscle and Reperfusion

作　　者：王稳[1] 苟志平[2] 

机构地区：[1]石河子大学医学院,新疆石河子832000 [2]克拉玛依市中心医院心内科,新疆克拉玛依834000

出　　处：《现代生物医学进展》2012年第19期3781-3783,3777,共4页Progress in Modern Biomedicine

摘　　要：近20年来,随着经皮冠状动脉介入(percutaneous coronary intervention,PCI)治疗的发展,相关的研究日益增多,许多研究显示炎症反应在行PCI治疗的患者的预后中发挥着很大的作用。PCI术后患者心肌再灌注的疗效日益引起人们的关注,尤其是再灌注无复流的危害和重要性,如何控制炎症因子(如hs-CRP,IL-6,TNF-α等)的水平,以有益于行PCI术的患者,需要更多一些前瞻性研究去观察。In recent 20 years, with the development of percutaneous coronary intervention treatment, the researches related to PCI are increasing. Many studies have shown that inflammation plays an important role in the prognosis of the patients who accepted the PCI treatment. The efficacy of myocardial reperfusion in these patients has attracted much attention, especially the damage and importance of the no-reflow reperfusion. How to control the levels of inflammatory factors （such as hs-CRP, IL-6, TNF-α, etc）, to benefits patie- nts undergoing PCI treatment, needs more prospective studies to observe.

关 键 词：炎症 冠心病 再灌注 急性冠脉综合症 不稳定斑块 

分 类 号：R541.4[医药卫生—心血管疾病]